EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

NCT05688241 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

EBV Lymphoma
Post-transplant Lymphoproliferative Disease (PTLD)

Interventions

DRUG: Donor-derived ex-vivo expanded EBV Tscm CTL

Sponsor

University Hospital, Basel, Switzerland